Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Product

RQ3025

1 clinical trial

1 indication

Indication
COVID-19
Clinical trial
An Interventional, Randomized, Parallel Controlled, Investigator Initiated Study to Investigate the Safety, Immunogenicity of Bivalent RQ3027 and RQ3025 mRNA Vaccine as a Booster Dose in 3 Doses COVID-19 Vaccine-Experienced Healthy Adults
Status: Completed, Estimated PCD: 2023-06-10